Premium
Independent association of matrix metalloproteinase‐10, cardiovascular risk factors and subclinical atherosclerosis
Author(s) -
ORBE J.,
MONTERO I.,
RODRÍGUEZ J. A.,
BELOQUI O.,
RONCAL C.,
PÁRAMO J. A.
Publication year - 2007
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2006.02276.x
Subject(s) - medicine , fibrinogen , odds ratio , asymptomatic , subclinical infection , gastroenterology , c reactive protein , risk factor , confidence interval , inflammation , cardiology
Summary. Objectives: Circulating levels of matrix metalloproteinase (MMP)‐10 are related to inflammation in asymptomatic subjects with cardiovascular risk factors. Whether MMP‐10 is associated with the severity of atherosclerosis remains to be determined. This study examines the relationship of systemic MMP‐10 levels with atherosclerotic risk factors and subclinical atherosclerosis. Methods and results: Circulating levels of MMP‐1, ‐9 and ‐10, and markers of inflammation [fibrinogen, interleukin‐6, von Willebrand factor, and high‐sensitivity C‐reactive protein (hs‐CRP)] were measured in 400 subjects (mean age 54.3 years, 77.7% men) with cardiovascular risk factors but free from clinical cardiovascular disease. Subclinical atherosclerosis was evaluated by both the mean carotid intima‐media thickness (IMT) and the presence of atherosclerotic plaques with the use of B‐mode ultrasound in all subjects. MMP‐10 levels were positively correlated with fibrinogen ( r = 0.24, P < 0.001), hs‐CRP ( r = 0.14, P < 0.01) and carotid IMT ( r = 0.17, P < 0.01). The association between MMP‐10 and IMT remained significant in multiple regression analysis ( P < 0.02) when controlling for traditional atherosclerotic risk factors and inflammatory markers. Such an association was not observed for MMP‐1 and ‐9. Subjects in the highest MMP‐10 tertile had significantly higher carotid IMT (adjusted odds ratio 6.3, 95% confidence interval 1.3–31.4, P = 0.024). In addition, MMP‐10 levels were significantly higher in patients with carotid plaques ( n = 78) than in those with no plaques after adjusting for age and sex ( P < 0.01). Conclusion: Higher serum MMP‐10 levels were associated with inflammatory markers, increased carotid IMT and atherosclerotic plaques in asymptomatic subjects. Circulating MMP‐10 may be useful to identify subclinical atherosclerosis in subjects free from cardiovascular disease.